In order for a drug to receive approval from the Food and Drug Administration it must go through clinical trials. This means testing on human subjects to prove that the drug is both safe and effective. People tend to make a lot of assumptions about FDA approval, and many people feel that as long as […]
FDA to Reduce Conflict of Interest
The FDA uses medical experts on its advisory committees who make recommendations on whether or not to approve potentially dangerous drugs and medical devices. While it is a great idea to get advice from experts, there is a problem. Many of their experts have a significant financial incentive for recommending either for or against a […]
Brain Injuries May Hold the Key to Stopping Addiction
According to a recent report in the journal Science, researchers have discovered that injury to the insula, a small region of the brain located near the ear, disrupts tobacco addiction. In the past addiction research focused on thinking and decision making regions of the cortex. This new discovery was made while studying stroke victims who […]
Bausch & Lomb Recalls
Discoloration and a Shorter Shelf Life In March 6, 2007, Bausch & Lomb did a voluntary recall of 12 lots of their lens care solution ReNu MultiPlus because they were expected to have a shorter shelf life than their expiration dates indicated, which would mean a loss of effectiveness. The Bausch & Lomb ReNu solution […]
Off Label Marketing and Zyprexa
When medications are approved by the FDA, they are normally approved for specific uses. Prescribing a drug for purposes other than what is has been approved for is called “off label” prescribing. Doctors can do that. It’s perfectly legal if they believe the drug will help the patient. Off label marketing is another story. When […]
- « Previous Page
- 1
- …
- 202
- 203
- 204
- 205
- 206
- …
- 236
- Next Page »
